Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.12.2 (
MEK
)
18,161
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Disrupted in schizophrenia 1
(
DISC1
) is known as a high susceptibility gene for schizophrenia. Recent studies have indicated that schizophrenia might be caused by glia defects and dysfunction. However, there is no direct evidence of a link between the schizophrenia gene
DISC1
and gliogenesis defects. Thus, an investigation into the involvement of
DISC1
(a ubiquitously expressed brain protein) in astrogenesis during the late stage of mouse embryonic brain development is warranted. Here, we show that suppression of
DISC1
expression represses astrogenesis in vitro and in vivo, and that
DISC1
overexpression substantially enhances the process. Furthermore, mouse and human
DISC1
overexpression rescued the astrogenesis defects caused by
DISC1
knockdown. Mechanistically,
DISC1
activates the RAS/
MEK
/ERK signaling pathway via direct association with RASSF7. Also, the pERK complex undergoes nuclear translocation and influences the expression of genes related to astrogenesis. In summary, our results demonstrate that
DISC1
regulates astrogenesis by modulating RAS/
MEK
/ERK signaling via RASSF7 and provide a framework for understanding how
DISC1
dysfunction might lead to neuropsychiatric diseases.
...
PMID:DISC1 regulates astrogenesis in the embryonic brain via modulation of RAS/MEK/ERK signaling through RASSF7. 2728 8